We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Top Sells

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$73.1M
2
DOV icon
Dover
DOV
+$41.7M
3
SLB icon
SLB Ltd
SLB
+$40M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$38.2M
5
WYNN icon
Wynn Resorts
WYNN
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PED icon
501
PEDEVCO
PED
$178M
$247K ﹤0.01%
2,740
+588
+27% +$93.2K
ETN icon
502
Eaton
ETN
$162B
$245K ﹤0.01%
3,611
-141
-4% -$9.3K
IMPV
503
DELISTED
Imperva, Inc.
IMPV
$245K ﹤0.01%
+4,950
New +$198K
PCL
504
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$245K ﹤0.01%
5,719
-1,505
-21% -$61.8K
WDAY icon
505
Workday
WDAY
$47.8B
$243K ﹤0.01%
+2,974
New +$257K
SCHX icon
506
Schwab US Large- Cap ETF
SCHX
$74.5B
$242K ﹤0.01%
29,562
– –
OKS
507
DELISTED
Oneok Partners LP
OKS
$242K ﹤0.01%
6,115
-32,780
-84% -$1.55M
IBB icon
508
iShares Biotechnology ETF
IBB
$10.8B
$241K ﹤0.01%
+2,385
New +$232K
PETX
509
DELISTED
Aratana Therapeutics, Inc.
PETX
$238K ﹤0.01%
+13,358
New +$166K
HSEA.CL
510
DELISTED
HSBC Holdings plc
HSEA.CL
$238K ﹤0.01%
9,000
– –
ALL icon
511
Allstate
ALL
$65.1B
$236K ﹤0.01%
3,364
-304
-8% -$20K
AJG icon
512
Arthur J. Gallagher & Co
AJG
$66.7B
$233K ﹤0.01%
4,941
-257
-5% -$12.1K
RDS.A
513
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$232K ﹤0.01%
3,712
+20
+0.5% +$1.29K
BTI icon
514
British American Tobacco
BTI
$121B
$230K ﹤0.01%
+4,260
New +$239K
CLX icon
515
Clorox
CLX
$12.5B
$229K ﹤0.01%
2,198
+1
+0% +$100
GS icon
516
Goldman Sachs
GS
$303B
$228K ﹤0.01%
+1,175
New +$221K
TGT icon
517
Target
TGT
$75.4B
$224K ﹤0.01%
2,955
-1,500
-34% -$101K
UYG icon
518
ProShares Ultra Financials
UYG
$840M
$224K ﹤0.01%
+9,000
New +$208K
DFS
519
DELISTED
Discover Financial Services
DFS
$223K ﹤0.01%
+3,407
New +$219K
SDY icon
520
State Street SPDR S&P Dividend ETF
SDY
$22B
$223K ﹤0.01%
+2,829
New +$221K
FANG icon
521
Diamondback Energy
FANG
$56.1B
$218K ﹤0.01%
+3,645
New +$232K
XLP icon
522
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$218K ﹤0.01%
+4,502
New +$213K
SLXP
523
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$217K ﹤0.01%
1,885
-315,169
-99% -$38.2M
CAG icon
524
Conagra Brands
CAG
$7.69B
$214K ﹤0.01%
+7,573
New +$207K
DVY icon
525
iShares Select Dividend ETF
DVY
$23.8B
$214K ﹤0.01%
2,694
-255
-9% -$19.7K
19 20
21
22 23

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.